Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
JYNNEOS vaccine coverage remains highly variable across jurisdictions with low uptake of the second dosage, as of November 2023 data.News Article updated on 01/08/2024
-
Positive Peers Mobile App
The Positive Peers app motivates youth and young adults with HIV to stay engaged in HIV care through self-management tools and virtual support. Although specific outcomes vary by age group, individuals who used the app were more likely to attend their medical appointments, receive labs, and reach viral suppression.Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
-
TransActivate: HIV Care Engagement for Transgender Latinas
Project to enhance the provision of HIV care for Latina transgender women in Los Angeles County.Resource updated 01/17/2024
-
Best Practices Highlight: New York City Medical Home Model
A New York City HIV medical home model has documented significant improvements in care re-engagement and viral suppression.Blog updated 08/23/2023
-
A Selection of Community Engagement Tools
Access these National Academy of Medicine and RWHAP consumer engagement tools.News Article updated on 06/23/2023 -
Bottom-Up Project
The Bottom-Up Project is a multi-organizational initiative focused on leveraging health information exchange data and peer navigation. Using real-time clinical data, in combination with linkage to HIV care and social services, the Bottom-Up Project locates and reengages people with HIV who are not currently in medical care and are not virally suppressed. Through this collaboration, over half of patients on the lost-to-follow-up list were found and invited to enroll in the linkage to care/reengagement program.Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
-
Clinical Trial: New Gonorrhea Treatment Effective
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.News Article updated on 11/16/2023 -
Integration of Buprenorphine into HIV Primary Care Settings: Curriculum
The purpose of this curriculum is to provide physicians with the information they need to educate their clinic staff and other stakeholders about integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care.
It provides a detailed overview of buprenorphine within clinical settings, from the legal requirements for implementation to step-by-step procedures for prescribing and administering buprenorphine.
Resource updated 03/12/2024
-
Integration of Buprenorphine into HIV Primary Care Settings: Training Manual
Overview of training manual on integrating buprenorphine treatment into HIV primary care.
Curriculum updated on 08/01/2012 -
Integration of Buprenorphine into HIV Primary Care Settings: Curriculum
Curriculum updated on 08/01/2012 -
Buprenorphine FAQ and Peer Discussion
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Curriculum updated on 09/05/2012 -
Apply now for June ESCALATE Ending Stigma Training for Community
Upcoming NMAC ESCALATE Training: June 17-21, Washington, DC Metro
This training focuses on combating HIV stigma and discrimination through cultural humility. This training will engage in tough conversations and tackle unconscious bias. Open to DMV locals (District of Columbia, Maryland, & Virginia)
Event updated 04/15/2024
-
New Tools on Quality Improvement and People with Lived Experience
Participation of people with lived experience in quality improvement work to enhance health outcomes of people with HIV.Blog updated 05/08/2024
-
Over 50,000 Health Professionals Trained: AETC 2022 Report
In 2021-2022, 56,383 health professionals received training in HIV clinical topics, provided by the HIV clinical training network under HRSA's Ryan White HIV/AIDS Program.News Article updated on 05/06/2024 -
Mpox Treatment Study Underway: How to Take Part
Insights on how to take part in the clinical trial are outlined in HIV.gov's Help Scientists Find a Safe and Effective Mpox Treatment.News Article updated on 05/17/2024 -
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
2024 National HIV Testing Day Theme Announcement
The National HIV Testing Day theme for 2024 is “Level up your self-love: check your status.”News Article updated on 05/28/2024 -
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023